European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology
- 25 September 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 37 (2), 164-173
- https://doi.org/10.1093/eurheartj/ehv497
Abstract
Aims Cardiomyopathies are a heterogeneous group of disorders associated with premature death due to ventricular arrhythmia or heart failure. The purpose of this study was to examine the characteristics of patients enrolled in the pilot phase of the EURObservational Research Programme (EORP) cardiomyopathy registry. Methods and results Between 1 December 2012 and 30 November 2013, four cardiomyopathy phenotypes were studied: hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), and restrictive cardiomyopathy (RCM). Twenty-seven centres in 12 countries participated; 1115 patients were enrolled. The commonest cardiomyopathy was HCM (n = 681), followed by DCM (n = 346), ARVC (n = 59), and RCM (n = 29); 423 patients (46.4% of those reported) had familial disease; and 56 (5.0%) had rare disease phenocopies. Median age at enrolment and diagnosis was 54 [interquartile range (IQR), 42–64] and 46 years (IQR, 32–58), respectively; fewer patients with ARVC and more with RCM were diagnosed in the upper age quartile (P < 0.0001). There was a male predominance for all cardiomyopathies except RCM (P = 0.0023). Most patients were in New York Heart Association functional class I (n = 813) at enrolment; 139 (12.5%) reported syncope, most frequently in ARVC (P = 0.0009). Five hundred and seven (45.5%) patients underwent cardiac magnetic resonance imaging, 117 (10.6%) endomyocardial biopsy, and 462 (41.4%) genetic testing with a causative mutation reported in 236 individuals (51.1%). 1026 patients (92.0%) were receiving drug therapy; 316 (28.3%) had received an implantable cardioverter defibrillator (highest proportion in ARVC, P < 0.0001). Conclusion This pilot study shows that services for patients with cardiomyopathy are complex, requiring access to a large range of invasive and non-invasive investigations and involvement of multidisciplinary teams. Treatment regimens are equally multifaceted and show that patients are likely to need long-term follow-up in close liaison with expert centres.Keywords
This publication has 24 references indexed in Scilit:
- The Spectrum of Epidemiology Underlying Sudden Cardiac DeathCirculation Research, 2015
- New Perspectives on the Prevalence of Hypertrophic CardiomyopathyJournal of the American College of Cardiology, 2015
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathyEuropean Heart Journal, 2014
- Risk stratification for sudden cardiac death: current status and challenges for the futureEuropean Heart Journal, 2014
- CardioPulse ArticlesEuropean Heart Journal, 2010
- Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseasesEuropean Heart Journal, 2007
- Contemporary Definitions and Classification of the CardiomyopathiesCirculation, 2006
- Circumstances of Death and Gross and Microscopic Observations in a Series of 200 Cases of Sudden Death Associated With Arrhythmogenic Right Ventricular Cardiomyopathy and/or DysplasiaCirculation, 2003
- Cardiovascular Causes of Sudden Death in Young Individuals Including AthletesCardiology in Review, 1999
- Epidemiology of dilated cardiomyopathy: A prospective post-mortem study of 5252 necropsiesEuropean Heart Journal, 1997